VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
173 hedge funds and large institutions have $726M invested in Meridian Bioscience Inc in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 67 increasing their positions, 51 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
60% less call options, than puts
Call options by funds: $655K | Put options by funds: $1.62M
Holders
173
Holding in Top 10
–
Calls
$655K
Puts
$1.62M
Top Buyers
| 1 | +$8.71M | |
| 2 | +$3.9M | |
| 3 | +$3.19M | |
| 4 |
Renaissance Technologies
New York
|
+$2.96M |
| 5 |
AAM
ACK Asset Management
Greenwich,
Connecticut
|
+$2.6M |
Top Sellers
| 1 | -$9.98M | |
| 2 | -$8.87M | |
| 3 | -$5.34M | |
| 4 |
EA
Emerald Acquisition
Seattle,
Washington
|
-$2.3M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.46M |